Drug
Cael 101
Cael 101: highest development phase Phase 3, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| CAEL-101 NCT04504825 | Phase 3 | AL Amyloidosis |
Latest
No recent events.
Follow Cael 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.